Abstract
Introduction

Cancer is a special kind of disease in which a group of cells display uncontrolled growth and it represents a serious assault on our quality of life. Developmental biology is a branch of biology that covers the total development process from the zygote to the adult with special focus on the embryo, because the embryo is the most important subject of the developmental biology and is a transition between genotype and phenotype [1]. With the recent profound advances in the field of developmental biology, it becomes apparent that the development of early embryo shares many similarities with cancer development in terms of both biological behaviours and molecular basis. This important view will promote the intersection between developmental biology and cancer biology and has twofold implications. On one hand, it enlightens us to study cancer from the perspective of developmental biology, which may reveal brand-new diagnostic and therapeutic targets for cancer. On the other hand, it suggests that we may envision embryo development as a process of tumour initiation and progression and incorporate decades of accumulation of cancer research theories, paradigms and models into our investigation of embryogenesis, thus enhancing our indepth understanding of this crucial process in our life history.
Embryonic origin of cancer
Early embryo development and tumourigenesis
Recently, considerable research has revealed the significant similarity between the development of early embryo and tumourigenesis in terms of biological behaviours such as migration and invasion [9], gene expression and protein profiles [10]
, signalling pathways [11] [12] , cell differentiation [13] , the mechanism of immune escape [14] , and so on. 
Similarity in cell invasive behaviours
Similarity in epigenetic regulation
Another significant similarity between tumourigenesis and early embryo development is epigenetic regulation. In the presence of DNA damage such as double strand breaks, the follicle cells might withdraw their processes from the maturing oocyte whereas the somatic cells might block information appropriate to a differentiated cell, thus leading to a genome-wide demethylation in both processes of the early development and tumourigenesis [7, [16] [17] [18] [19] [20] . Although genome-wide demethylation is observed in embryo and cancer, it is fantastic that the level of DNA methyltransferases [7, [16] [17] [18] [19] [20] is actually very high in embryos [21] and tumours [22] [23] [26] [27] . In addition, a range of other diagnostic oncofetal biomarkers have been identified including ␣-fetoprotein [28] [29] , squamous cell antigen [30] [31] , survivin [32] [33] , cancer antigen 199 [34] [35] , prostate specific antigen [36] [37] , tissue polypeptide-specific antigen [38] [39] and human chorionic gonadotropin [40] [41] .
Similarity in protein profiling
It is well known that some proteins typically present only during foetal development are also found in adults with certain kinds of cancer and are called oncofetal proteins. These proteins have been demonstrated to play important roles in cancer, and therefore have been used as common biomarkers in early diagnosis, treatment and prognosis of a variety of cancers. At present, oncofetal biomarkers are mainly divided into four categories: proteins (antigen), carbohydrates, glycolipids and hormones. Among them, carcinoembryonic antigen (CEA) is the most widely used oncofetal tumour biomarker applied to clinical cancer diagnosis
The expression of these proteins in cancer and during early embryo development has an extremely important implication regarding cell differentiation and proliferation. Furthermore, the examination of these oncofetal proteins in biological fluids and the corresponding tumour tissues has been proposed to explain the similar immunological mechanisms between the tumourigenesis and early embryo development. tumour cells produce and release the proteins into the circulation, such as tumour associated antigens, sharing the same mechanism of immune escape with foetal development [11] . It was found that the maternal serum levels of three tumour-associated antigens CEA, CA 228 and CA 15-3 were elevated during the three trimesters of pregnancy in healthy women [42] [43] . Dvorak et al. [44] [24] ; (3) the similarity of the immune escape mechanisms [26] [27] [28] ; (4) [46] . Thus, it is tempting to imagine a scenario in which tumour recapitulates these developmental signalling pathways to drive tumour progression (Fig. 1) . 
Conclusion
